• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Using HIEs to Prepopulate Forms Improves Public Health Disease Reporting, Study Finds

Share:

June 24, 2020

Leveraging electronic health information exchanges (HIE) to prepopulate forms for notifiable disease reports increases reporting and completeness of information, according to a new study from Regenstrief Institute and Indiana University. Published in the May/June edition of Public Health Reports, the two-year controlled before-and-after trial reveals HIE-generated forms increases provider reporting rates for notifiable conditions.

COVID-19 Pandemic Underscores Importance of Disease Tracking

Disease tracking is an important area of focus for health departments in the midst of the COVID-19 pandemic. Typically, health departments wait for hospital, laboratory, or clinic staff members to initiate the report, and it is commonly done by fax. This process can be burdensome to those charged with filing the paperwork and the public health officials who analyze it, leading to delays or gaps in reporting.

HIE-Generated Forms Study Details

The objective of this study was to determine the effect of an electronic, prepopulated notifiable disease report form on case reporting rates by ambulatory care clinics to public health authorities. Led by researchers Brian Dixon, Ph.D., and Shaun Grannis, M.D. of Regenstrief Institute, the two-year controlled before-and-after trial analyzed reports submitted to a local health department for seven notifiable diseases. The research scientists compared “usual care,” which is the use of paper and fax reports, with HIE-generated forms.

To create the forms, the research team designed a clinical decision support tool that is triggered when an electronic laboratory message is examined by the Regenstrief Notifiable Condition Detector. The system extracts data from the Indiana Health Information Exchange and fills in the information fields on the official state reporting form. The form is delivered to an ambulatory care clinic using the HIE network, acting as a reminder for the clinician or staff member to review and submit the form to the local health department.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We know that filling out forms can be challenging for providers and their staff for many reasons,” said Shaun Grannis, M.D., M.S., senior author and vice president for data and analytics at Regenstrief. “Our solution facilitates public health reporting, which is crucial, while also allowing providers to do what they do best-providing care for their patients.” Dr. Grannis is also a professor of family medicine at Indiana University School of Medicine.

Study Outcomes/Results

They found that provider reporting rates for chlamydia and gonorrhea increased significantly in clinics using the HIE-generated forms, and completeness significantly improved for 4 of the 15 information fields on the reporting forms. Provider reporting rates for chlamydia and gonorrhea in intervention clinics increased significantly from 56.9% and 55.6%, respectively, during the baseline period (2012) to 66.4% and 58.3%, respectively, during the intervention period (2013-2014); they decreased from 28.8% and 27.5%, respectively, to 21.7% and 20.6%, respectively, in control clinics (P < .001).

In addition, 75 percent of cases reported by intervention clinics contained a prepopulated form, which indicates that clinics are willing to use the tool. Timeliness improved for both intervention and control clinics; however, reports from control clinics were timelier (mean, 7.9 days) than reports from intervention clinics (mean, 9.7 days).

The research team stressed the importance of continuing to build better integration between clinical and public health information systems. “As demonstrated by the COVID-19 pandemic, timely and complete reporting is crucial to enable quick response to outbreaks that threaten the health of the public,” said Dr. Dixon. “As we continue to track the spread of COVID-19 and other diseases, interoperability will play a key role in informing decisions. The healthcare field must continue to push forward in its effort to refine technical and workflow processes to make public health surveillance more efficient.”

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • ‘Dramatic’ Placebo Effect Trips Relmada’s MDD Hopeful for the Second Time‘Dramatic’ Placebo Effect Trips Relmada’s MDD Hopeful for the Second Time
  • 3 Ways AI and Machine Learning Are Reshaping Medical Records3 Ways AI and Machine Learning Are Reshaping Medical Records
  • Calyptus Pharmaceuticals Announces Partnership with Provepharm to Accelerate Development of An Acute Care Injectable ProductCalyptus Pharmaceuticals Announces Partnership with Provepharm to Accelerate Development of An Acute Care Injectable Product
  • Artificial intelligence is making tech companies the new healthcare giantsArtificial intelligence is making tech companies the new healthcare giants
  • New Mental Health app Offers Tool to Help Combat Stress for LondonersNew Mental Health app Offers Tool to Help Combat Stress for Londoners
  • Study: In-home Healthcare Expansion Requires Overcoming Market and Technical BarriersStudy: In-home Healthcare Expansion Requires Overcoming Market and Technical Barriers
  • CVR Medical Agrees Proposed Acquisition of CVR GlobalCVR Medical Agrees Proposed Acquisition of CVR Global
  • Vipergen Establishes Partnership with Anavo Therapeutics to Support Phosphatase-Targeted Discovery ProgramsVipergen Establishes Partnership with Anavo Therapeutics to Support Phosphatase-Targeted Discovery Programs

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications